Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar;178(5):1218-1233.
doi: 10.1111/bph.15366. Epub 2021 Feb 3.

Deep sequencing of prostaglandin-endoperoxide synthase (PTGE) genes reveals genetic susceptibility for cross-reactive hypersensitivity to NSAID

Elena García-Martín  1 , Jesús M García-Menaya  2 , Gara Esguevillas  1 , José A Cornejo-García  3 , Inmaculada Doña  4 , Raquel Jurado-Escobar  3 , María J Torres  4 , Natalia Blanca-López  5 , Gabriela Canto  5 , Miguel Blanca  5 , José J Laguna  6 , Joan Bartra  7 , Ana Rosado  8 , Javier Fernández  9 , Concepción Cordobés  2 , José A G Agúndez  1
Affiliations
Free article

Deep sequencing of prostaglandin-endoperoxide synthase (PTGE) genes reveals genetic susceptibility for cross-reactive hypersensitivity to NSAID

Elena García-Martín et al. Br J Pharmacol. 2021 Mar.
Free article

Abstract

Background and purpose: Cross-reactive hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) is a relatively common adverse drug event caused by two or more chemically unrelated drugs and that is attributed to inhibition of the COX activity, particularly COX-1. Several studies investigated variations in the genes coding for COX enzymes as potential risk factors. However, these studies only interrogated a few single nucleotide variations (SNVs), leaving untested most of the gene sequence.

Experimental approach: In this study, we analysed the whole sequence of the prostaglandin-endoperoxide synthase genes, PTGS1 and PTGS2, including all exons, exon-intron boundaries and both the 5' and 3' flanking regions in patients with cross-reactive hypersensitivity to NSAIDs and healthy controls. After sequencing analysis in 100 case-control pairs, we replicated the findings in 540 case-control pairs. Also, we analysed copy number variations for both PTGS genes.

Key results: The most salient finding was the presence of two PTGS1 single nucleotide variations, which are significantly more frequent in patients than in control subjects. Patients carrying these single nucleotide variations displayed a significantly and markedly lower COX-1 activity as compared to non-carriers for both heterozygous and homozygous patients.

Conclusion and implications: Although the risk single nucleotide variations are present in a small proportion of patients, the strong association observed and the functional effect of these single nucleotide variations raise the hypothesis of genetic susceptibility to develop cross-reactive NSAID hypersensitivity in individuals with an impairment in COX-1 enzyme activity.

Keywords: NSAID; PTGS1; PTGS2; cycloxygenase; hypersensitivity.

PubMed Disclaimer

References

REFERENCES

    1. Agundez, J. A., Blanca, M., Cornejo-Garcia, J. A., & Garcia-Martin, E. (2015). Pharmacogenomics of cyclooxygenases. Pharmacogenomics, 16(5), 501-522. https://doi.org/10.2217/pgs.15.6
    1. Agundez, J. A., Garcia-Martin, E., & Martinez, C. (2009). Genetically based impairment in CYP2C8- and CYP2C9-dependent NSAID metabolism as a risk factor for gastrointestinal bleeding: Is a combination of pharmacogenomics and metabolomics required to improve personalized medicine? Expert Opinion on Drug Metabolism & Toxicology, 5(6), 607-620. https://doi.org/10.1517/17425250902970998
    1. Agundez, J. A., Gonzalez-Alvarez, D. L., Vega-Rodriguez, M. A., Botello, E., & Garcia-Martin, E. (2014). Gene variants and haplotypes modifying transcription factor binding sites in the human cyclooxygenase 1 and 2 (PTGS1 and PTGS2) genes. Current Drug Metabolism, 15(2), 182-195. https://doi.org/10.2174/138920021502140327180336
    1. Agundez, J. A., Martinez, C., Perez-Sala, D., Carballo, M., Torres, M. J., & Garcia-Martin, E. (2009). Pharmacogenomics in aspirin intolerance. Current Drug Metabolism, 10(9), 998-1008. https://doi.org/10.2174/138920009790711814
    1. Alexander, S. P. H., Christopoulos, A., Davenport, A. P., Kelly, E., Mathie, A., Peters, J. A., … Pawson, A. J. (2019). The concise guide to pharmacology 2019/20: G protein-coupled receptors. British Journal of Pharmacology, 176(Suppl 1), S21-S141.

Publication types

MeSH terms

Substances

LinkOut - more resources